Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - farmorubicintm cs (epirubicin hydrochloride) has a significant therapeutic response in several neoplasms, among them: breast carcinoma, malignant lymphomas, soft tissue sarcomas, gastric carcinoma, liver cancer, pancreatic cancer, rectum-sigmoid carcinoma, carcinoma of the cervix-facial region, pulmonary carcinoma, ovarian carcinoma and leukemia?s. farmorubicintm cs by intravesical instillation is indicated in treatment of superficial bladder carcinomas (transitional cell carcinoma, in situ carcinoma) and in the prophylaxis of relapses after transurethral resection.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - farmorubicina? cs is indicated for the treatment of many kinds of cancers: breast carcinoma, lymphomas, soft tissue sarcomas, gastric carcinoma, hepatic carcinoma, pancreatic cancer, rectal-sigmoid carcinoma, cervix-facial region carcinoma, lung carcinoma, ovarian carcinoma, leukaemia and bladder cancer.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - farmorubicina has shown to be effective in a wide range of neoplastic diseases such as: - breast carcinoma. - soft tissue sarcoma - gastric carcinoma. - small cell lung carcinoma. - advanced ovarian carcinoma. farmorubicina may also be used in the treatment of transitional cell bladder carcinoma (ta/t1 and carcinoma in situ) and in the prophylaxis of the rebound of transitional cell bladder tumours with complete transurethral resection. farmorubicina may also be used alone as a single agent or as part of different kinds of polichemotherapy treatments.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - farmorubicina tm cs (epirubicin hydrochloride) has a significant therapeutic response in several neoplasms such as: breast carcinoma, malignant lymphomas, soft tissue sarcomas, gastric carcinoma, liver carcinoma, pancreatic cancer, rectum-sigmoid carcinoma, cervical-facial carcinoma, pulmonary carcinoma, ovarian carcinoma and leukemias. farmorubicina tm cs by intravesical instillation is indicated to treat superficial bladder carcinoma (of transitional cells, carcinoma in situ) and for prophylaxis of recurrences after trans-urethral resection.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - farmorubicina is used in adults to treat different types of tumour: ? breast cancer; ? malignant lymph node tumours (lymphoma); ? soft tissue tumours (sarcomas); - cancer of the stomach and intestine (sigmoid rectal cancer) ? liver cancer; ? pancreatic cancer; ? cancer of the head or neck (cervical and facial segment) ? lung cancer; ? ovarian cancer; farmorubicina 10 mg/5 ml e 50 mg/25 ml is also administered directly into the bladder (intravesical route), in the treatment of early (superficial) bladder cancer and to prevent bladder cancer relapse after surgery (transurethral resection). blood cancer (leukaemia).

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - .farmorubicina is used in adults to treat different types of tumour: ? breast cancer; ? malignant lymph node tumours (lymphoma); ? soft tissue tumours (sarcomas); - cancer of the stomach and intestine (sigmoid rectal cancer) ? liver cancer; ? pancreatic cancer; ? cancer of the head or neck (cervical and facial segment) ? lung cancer; ? ovarian cancer; ? blood cancer (leukaemia).

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - farmorubicin has been shown to be particularly effective in the treatment of breast, ovarian, stomach, colon and lung cancers. furthermore, farmorubicin may be used in the treatment of cancer of the blood-forming organs such as malignant lymphomas, leukaemia and multiple myeloma. farmorubicin may also be injected directly through a tube into the urinary bladder. this method is sometimes used in the treatment of cell abnormalities or bladder wall cancer. it can also be used after other forms of treatment as an attempt to prevent the re-growth of such cells.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - farmorubicin has been shown to be particularly effective in the treatment of breast, ovarian, stomach, colon and lung cancers. furthermore, farmorubicin may be used in the treatment of cancer of the blood-forming organs such as malignant lymphomas, leukaemia and multiple myeloma. farmorubicin may also be injected directly through a tube into the urinary bladder. this method is sometimes used in the treatment of cell abnormalities or bladder wall cancer.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - farmorubicin pfs is recommended for use in the treatment of the following types of cancer: - transitional cell bladder cancer - early-stage, advanced and/or metastatic breast cancer - gastric cancer - palliative chemotherapy for cancer of the oesophago-gastric junction - head and neck cancers - leukaemia - non-small cell lung cancer (nsclc) - small cell lung cancer (sclc) - non-hodgkin lymphomas (nhls), hodgkin lymphoma (hl) - multiple myeloma - ovarian cancer - pancreatic cancer treated with the combined cisplatin, epirubicin, 5-fluorouracil and gemcitabine (pefg) regimen - bowel cancer - soft tissue sarcomas.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - farmorubicin can be used alone or in combination with other medicines, in treatment of the following types of cancers: - breast cancer. - soft tissue sarcoma: malignant tumors that can affect the cartilage, muscles, fat, blood vessels, or others. - stomach cancer. - small cell lung cancer (a special type of lung cancer). - advanced ovarian cancer. - early (superficial) tumors of the bladder and as possible prevention of relapses after surgery. ?